Patent Settlements: 2nd Circuit Okays Bayer's Cipro Deal But Doesn't Want To

While the U.S. Court of Appeals for the Second Circuit found that a reverse settlement agreement involving Bayer's antibiotic Cipro did not violate antitrust laws, it invited the plaintiffs to seek a reexamination of the case by the full court